1. Bufexamac withdrawn from Australian market due to allergic dermatitis

   News item 03 October 2020 Pages: 1 - 1

2. Depressed mood disorders with anastrozole

   News item 03 October 2020 Pages: 2 - 2

3. EMA's CHMP meeting highlights from September 2020

   News item 03 October 2020 Pages: 3 - 3

4. MRHA changes safety-critical alerts for medicines and devices

   News item 03 October 2020 Pages: 4 - 4

5. Revised guidance for use of antibacterials for otitis media in Japan

   News item 03 October 2020 Pages: 5 - 5

6. NICE to ensure integrated approach to following safety recommendations

   News item 03 October 2020 Pages: 6 - 6

7. Antibiotic use associated with appendicitis in paediatric patients?

   Clinical study 03 October 2020 Pages: 7 - 7

8. Communication of teratogenicity risk with dolutegravir

   Clinical study 03 October 2020 Pages: 8 - 8

9. Hydroxychloroquine in early pregnancy: risk of birth defects

   Clinical study 03 October 2020 Pages: 9 - 9

10. Hydroxychloroquine- and chloroquine-related cardiovascular events

    Clinical study 03 October 2020 Pages: 10 - 10

11. Sex differences in ADR reports for drugs used to treat COVID-19

    Clinical study 03 October 2020 Pages: 11 - 11

12. Which medications do pregnant women use disproportionately?

    Clinical study 03 October 2020 Pages: 12 - 12

13. Other adverse reaction research

    News item 03 October 2020 Pages: 13 - 13

14. Adalimumab/methotrexate

    Case report 03 October 2020 Pages: 14 - 14

15. Aflibercept

    Case report 03 October 2020 Pages: 15 - 15

16. Alendronic-acid

    Case report 03 October 2020 Pages: 16 - 16

17. Alteplase/desmopressin/testosterone

    Case report 03 October 2020 Pages: 17 - 17

18. Aminolevulinic-acid

    Case report 03 October 2020 Pages: 18 - 18

19. Amiodarone

    Case report 03 October 2020 Pages: 19 - 19

20. Amiodarone/antibacterials/atorvastatin

    Case report 03 October 2020 Pages: 20 - 20

21. Amiodarone/bisoprolol

    Case report 03 October 2020 Pages: 21 - 21

22. Amoxicillin

    Case report 03 October 2020 Pages: 22 - 22

23. Amoxicillin/clavulanic acid

    Case report 03 October 2020 Pages: 23 - 23

24. Amphotericin-B liposomal

    Case report 03 October 2020 Pages: 24 - 24

25. Amphotericin-B liposomal/immunosuppressants/voriconazole

    Case report 03 October 2020 Pages: 25 - 25

26. Amphotericin-B/immunosuppressants/posaconazole

    Case report 03 October 2020 Pages: 26 - 26

27. Anti cancers

    Case report 03 October 2020 Pages: 27 - 27

28. Antibacterials

    Case report 03 October 2020 Pages: 28 - 28

29. Antibacterials/atorvastatin/simvastatin

    Case report 03 October 2020 Pages: 29 - 29

30. Antibiotics/antineoplastics/steroids

    Case report 03 October 2020 Pages: 30 - 30

31. Anticoagulants

    Case report 03 October 2020 Pages: 31 - 31

32. Anticoagulants/antiplatelets

    Case report 03 October 2020 Pages: 32 - 32

33. Antiepileptic drugs

    Case report 03 October 2020 Pages: 33 - 33

34. Antiepileptics

    Case report 03 October 2020 Pages: 34 - 34

35. Antiepileptics/anaesthetics

    Case report 03 October 2020 Pages: 35 - 35

36. Antifungals/methylprednisolone/plasma

    Case report 03 October 2020 Pages: 36 - 36

37. Antineoplastics

    Case report 03 October 2020 Pages: 37 - 37

38. Antineoplastics

    Case report 03 October 2020 Pages: 38 - 38

39. Antineoplastics

    Case report 03 October 2020 Pages: 39 - 39

40. Antineoplastics

    Case report 03 October 2020 Pages: 40 - 40

41. Antineoplastics

    Case report 03 October 2020 Pages: 41 - 41

42. Antineoplastics

    Case report 03 October 2020 Pages: 42 - 42

43. Antineoplastics

    Case report 03 October 2020 Pages: 43 - 43

44. Antineoplastics

    Case report 03 October 2020 Pages: 44 - 44

45. Antineoplastics

    Case report 03 October 2020 Pages: 45 - 45

46. Antineoplastics

    Case report 03 October 2020 Pages: 46 - 46

47. Antineoplastics

    Case report 03 October 2020 Pages: 47 - 47

48. Antineoplastics/epoetin-β/pegfilgrastim

    Case report 03 October 2020 Pages: 48 - 48

49. Antipsychotics

    Case report 03 October 2020 Pages: 49 - 49

50. Antithymocyte-globulin/belatacept/steroids

    Case report 03 October 2020 Pages: 50 - 50